Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.

Silicon Valley microprocessing giant NVIDIA and pharma powerhouse Eli Lilly announced a five-year, $1 billion partnership to create a “Co-Innovation AI Lab” designed to address key challenges in AI ...

Researchers say the living sensor display technology may have potential applications beyond human healthcare, in veterinary ...

Charles River Laboratories will pay $60 million for the remaining shares of PathoQuest and $510 million for acquiring K.F.

A novel lentiviral packaging system enables production from a single-plasmid transfection instead of the standard four-plasmid process.

The largest single cell perturbation dataset to-date will be generated and released open source in a new team effort.

Data indicate that the AutoCell platform could pave the way for CGTs for the first time as first-line therapies.

Trained on 9.7 trillion tokens of evolutionary data, EDEN designs therapeutics from large gene insertion to antimicrobial peptides.

PanMAN data structures compress pangenomes massively, encode evolutionary histories, and enable scalable analysis of millions of genomes.

Researchers suggest that, from a clinical perspective, the findings provide mechanistic insight into motivational deficits central to psychiatric disorders.

The year 2026 will likely see an increase in the number as well as dollar value of merger and acquisition (M&A) deals, according to a report released to coincide with the 43rd Annual J.P. Morgan ...

Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...